Estradiol-activated estrogen receptor α does not regulate mature microRNAs in T47D breast cancer cells

被引:22
作者
Katchy, Anne [1 ]
Edvardsson, Karin [1 ,2 ]
Aydogdu, Eylem [1 ]
Williams, Cecilia [1 ]
机构
[1] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77204 USA
[2] Karolinska Inst, Dept Biosci & Nutr, S-14183 Stockholm, Sweden
关键词
Breast cancer; microRNA; Estrogen receptor; C-MYC; TRANSCRIPTIONAL RESPONSE; ONCOGENE EXPRESSION; GENE-EXPRESSION; GENOME-WIDE; MODULATION;
D O I
10.1016/j.jsbmb.2011.10.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Breast cancers are sensitive to hormones such as estrogen, which binds to and activates estrogen receptors (ER) leading to significant changes in gene expression. microRNAs (miRNA) have emerged as a major player in gene regulation, thus identification of miRNAs associated with normal or disrupted estrogen signaling is critical to enhancing our understanding of the diagnosis and prognosis of breast cancer. We have previously shown that 17 beta-estradiol (E2) induced activation of ER alpha in T47D cells results in significant changes in the expression of protein-coding genes involved in cell cycle, proliferation, and apoptosis. To identify miRNAs regulated by E2-activated ER alpha, we analysed their expression in T47D cells following E2-activation using both dual-color microarrays and TagMan Low Density Arrays, and validations were carried out by real-time PCR. Although estrogen treatment results in altered expression of up to 900 protein-coding transcripts, no significant changes in mature miRNA expression levels could be confirmed. Whereas previous studies aiming to elucidate the role of miRNA in ER-positive breast cancers cell lines have yielded conflicting results, the work presented here represents a thorough investigation of and significant step forward in our understanding of ER alpha mediated miRNA regulation. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:145 / 153
页数:9
相关论文
共 50 条
  • [31] Inhibition of proliferation of T47D human breast cancer cells: Alterations in progesterone receptor and p53 tumor suppressor protein
    Dinda, S
    KodaliGali, S
    Sevilla, L
    Burkley, M
    Hurd, C
    Moudgil, VK
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 1997, 175 (1-2) : 81 - 89
  • [32] Effects of the activated mitogen-activated protein kinase pathway via the c-ros receptor tyrosine kinase on the T47D breast cancer cell line following alcohol exposure
    Lee, Hyung Tae
    Kim, Se Kye
    Choi, Mi Ran
    Park, Ji Hyun
    Jung, Kyoung Hwa
    Chai, Young Gyu
    [J]. ONCOLOGY REPORTS, 2013, 29 (03) : 868 - 874
  • [33] Inhibition of proliferation of T47D human breast cancer cells: Alterations in progesterone receptor and p53 tumor suppressor protein
    Sumi Dinda
    Sandhya Kodali-Gali
    Lisa Sevilla
    Michael Burkley
    Cliff Hurd
    V.K. Moudgil
    [J]. Molecular and Cellular Biochemistry, 1997, 175 : 81 - 89
  • [34] Differential modulation by estradiol of P-glycoprotein drug resistance protein expression in cultured MCF7 and T47D breast cancer cells
    Zampieri, L
    Bianchi, P
    Ruff, P
    Arbuthnot, P
    [J]. ANTICANCER RESEARCH, 2002, 22 (04) : 2253 - 2259
  • [35] ATP Depletion as a Consequence of Hypoxia Enhances Tamoxifen Antiproliferative Effects in T47D Breast Carcinoma Cells
    Seyedabadi, M.
    Ghahremani, M. H.
    Ostad, S. N.
    [J]. ONCOLOGY RESEARCH, 2009, 18 (5-6) : 221 - 228
  • [36] Opioids are non-competitive inhibitors of nitric oxide synthase in T47D human breast cancer cells
    Kampa, M
    Hatzoglou, A
    Notas, G
    Niniraki, M
    Kouroumalis, E
    Castanas, E
    [J]. CELL DEATH AND DIFFERENTIATION, 2001, 8 (09) : 943 - 952
  • [37] Epidermal growth factor suppresses induction by progestin of the adhesion protein desmoplakin in T47D breast cancer cells
    Pang, HY
    Rowan, BG
    Al-Dhaheri, M
    Faber, LE
    [J]. BREAST CANCER RESEARCH, 2004, 6 (03): : R239 - R245
  • [38] Epidermal growth factor suppresses induction by progestin of the adhesion protein desmoplakin in T47D breast cancer cells
    Haiyan Pang
    Brian G Rowan
    Mariam Al-Dhaheri
    Lee E Faber
    [J]. Breast Cancer Research, 6
  • [39] Bioenergetic differences between MCF-7 and T47D breast cancer cells and their regulation by oestradiol and tamoxifen
    Radde, Brandie N.
    Ivanova, Margarita M.
    Mai, Huy Xuan
    Salabei, Joshua K.
    Hill, Bradford G.
    Klinge, Carolyn M.
    [J]. BIOCHEMICAL JOURNAL, 2015, 465 : 49 - 61
  • [40] Opioids are non-competitive inhibitors of nitric oxide synthase in T47D human breast cancer cells
    M Kampa
    A Hatzoglou
    G Notas
    M Niniraki
    E Kouroumalis
    E Castanas
    [J]. Cell Death & Differentiation, 2001, 8 : 943 - 952